tiprankstipranks
Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market
Holding RLAY?
Track your performance easily

Relay Therapeutics (RLAY) Technical Analysis

405 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
0Neutral
15Bearish
Technical Analysis Consensus
Buy
7Bullish
0Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Relay Therapeutics’s (RLAY) Moving Averages Convergence Divergence (MACD) indicator is -0.27, suggesting Relay Therapeutics is a Buy.
Relay Therapeutics’s (RLAY) 20-Day exponential moving average is 6.00, while Relay Therapeutics’s (RLAY) share price is $5.105, making it a Sell.
Relay Therapeutics’s (RLAY) 50-Day exponential moving average is 6.44, while Relay Therapeutics’s (RLAY) share price is $5.105, making it a Sell.

Relay Therapeutics (RLAY) Pivot Points

Nov 21, 2024, 05:48 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.24
5.41
5.51
5.68
5.78
5.95
6.05
Fibonacci
5.41
5.52
5.58
5.68
5.79
5.85
5.95
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Relay Therapeutics (RLAY) Moving Averages

Nov 21, 2024, 05:48 PM
Period
Simple
Exponential
MA5
5.72Sell
5.60Sell
MA10
5.90Sell
5.79Sell
MA20
5.99Sell
6.00Sell
MA50
6.71Sell
6.44Sell
MA100
7.03Sell
6.85Sell
MA200
7.41Sell
7.59Sell
Relay Therapeutics’s (RLAY) 10-Day exponential moving average is 5.79, while Relay Therapeutics’s (RLAY) share price is $5.105, making it a Sell.
Relay Therapeutics’s (RLAY) 100-Day exponential moving average is 6.85, while Relay Therapeutics’s (RLAY) share price is $5.105, making it a Sell.
Relay Therapeutics’s (RLAY) stock price is $5.105 and Relay Therapeutics’s (RLAY) 50-day simple moving average is 6.71, creating a Sell signal.
Relay Therapeutics’s (RLAY) stock price is $5.105 and Relay Therapeutics’s (RLAY) 100-day simple moving average is 7.03, creating a Sell signal.
Relay Therapeutics’s (RLAY) stock price is $5.105 and Relay Therapeutics’s (RLAY) 200-day simple moving average is 7.41, creating a Sell signal.

Relay Therapeutics (RLAY) Technical Indicators

Nov 21, 2024, 05:48 PM
Name
Value
Implied Action
RSI (14)
28.49
Buy
STOCH (9,6)
8.85
Buy
STOCHRSI (14)
9.73
Buy
MACD (12,26)
-0.27
Buy
ADX (14)
18.77
Buy
Williams %R
-95.24
Buy
CCI (14)
-211.00
Buy
ATR (14)
0.39
-
Ultimate Oscillator
26.79
Sell
ROC
-15.42
Sell
Relay Therapeutics’s (RLAY) Relative Strength Index (RSI) is 28.49, creating a Buy signal.
Relay Therapeutics’s (RLAY) Trend Strength Indicator (ADX) is 18.77, creating a Buy signal.
Relay Therapeutics’s (RLAY) Commodity Channel Index (CCI) is -211.00, creating a Buy signal.
Relay Therapeutics’s (RLAY) Price Rate of Change (ROC) is -15.42, creating a Sell signal.

FAQ

Is RLAY a Buy, Hold, or Sell?
Based on RLAY’s technical indicators, RLAY is a Sell.
    What is RLAY’s RSI (14)?
    RLAY’s RSI (14) is 28.49, which suggests RLAY is a Buy.
      What is RLAY’s MACD?
      RLAY’s MACD is -0.27, which suggests RLAY is a Buy.
        What is RLAY’s 5-day moving average?
        RLAY’s 5-day moving average is 5.72, which suggests RLAY is a Sell.
          What is RLAY’s 20-day moving average?
          RLAY 20-day moving average is 5.99, which suggests RLAY is a Sell.
            What is RLAY’s 50-day moving average?
            RLAY’s 50-day moving average is 6.71, which suggests RLAY is a Sell.
              What is RLAY’s 200-day moving average?
              RLAY’s 200-day moving average is 7.41, which suggests RLAY is a Sell.
                What is RLAY’s Williams % R (14)?
                RLAY’s Williams % R (14) is -95.24, which suggests RLAY is a Buy.
                  What is RLAY’s CCI (14)?
                  RLAY’s CCI (14) is -211.00, which suggests RLAY is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis